Hitachi and Axcelead have entered a partnership to develop solutions contributing to more efficient creation of next-generation biopharmaceuticals with digital technology and drug discovery.
Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.